NFATc1 as a therapeutic target in FLT3-ITD-positive AMLStephan Metzelder, Andreas Burchert, Kristina Sohlbach et al.|Leukemia|2015Cited by 52
Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemiaChristian Michel, Andreas Burchert, Elisabeth Mack et al.|Haematologica|2019Cited by 0
P-011 Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/ refractory multiple myeloma are associated with pre-CAR-T bridging therapiesJan Frenking, Marc S. Raab, Joseph Kauer et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myelomaMartin Grözinger, Lukas John, M Schlanke et al.|Leukemia|2025Cited by 0